Preliminary Evaluation of a Long-Term Intraperitoneal Glucose Sensor With Flushing Mechanism.

Competing Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: DRB is a founder and CEO of Theranova, LLC. He is a coinventor of patents related to the device reported here. Theranova, LLC is the owner and developer of an intraperitoneal artificial pancreas and holds multiple patents related to this product. ESL and AY are employees of Theranova, LLC and co-inventor of patents related to the device. HCZ is a paid consultant to Theranova. DRB, ESL, and AY have equity interests in the artificial pancreas technology. LMH from UCSB, and ED and FJD from UCSB and Harvard do not have any competing financial interests in this work that could be perceived as a conflict of interest.